FDA analyses find trial-to-trial variation in the analysis of patient reported outcomes, underscoring the need for standardization.
Jonathan Wosen, PhD
Jonathan Wosen is a freelance science journalist who holds a PhD in immunology from Stanford University. He has written for STAT News, Stanford University School of Medicine, the Santa Cruz Sentinel, and Genetic Engineering & Biotechnology News. Jonathan is currently enrolled in the UC Santa Cruz Science Communication Program.